ImmuCell Corporation

NASDAQ: ICCC · Real-Time Price · USD
5.04
-0.23 (-4.36%)
At close: May 06, 2025, 3:32 PM
5.07
0.60%
After-hours: May 06, 2025, 04:05 PM EDT
-4.36%
Bid 4.8
Market Cap 45.33M
Revenue (ttm) 26.49M
Net Income (ttm) -2.16M
EPS (ttm) -0.26
PE Ratio (ttm) -19.38
Forward PE -48.09
Analyst n/a
Ask 5.3
Volume 12,641
Avg. Volume (20D) 18,983
Open 5.11
Previous Close 5.27
Day's Range 5.04 - 5.27
52-Week Range 3.34 - 5.82
Beta 0.24

About ICCC

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides Ca...

Industry Biotechnology
Sector Healthcare
IPO Date May 5, 1987
Employees 69
Stock Exchange NASDAQ
Ticker Symbol ICCC
Full Company Profile
10 months ago
+0%
ImmuCell shares are trading higher after the compa... Unlock content with Pro Subscription